Evidence map›Paper›PMID 23947598›Full record

ArticleAmerican journal of respiratory cell and molecular biology2014

Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis.

Ana Paula T Monteiro, Erico Soledade, Carla S Pinheiro, Ludmilla Dellatorre-Teixeira, Gisele P Oliveira, Mariana G Oliveira, Marc Peters-Golden, Patricia R M Rocco, Claudia F Benjamim, Claudio Canetti

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Isoflurane attenuates sepsis-associated lung injury.Biochemical and biophysical research communications · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Paternal diet programs offspring health through sperm- and seminal plasma-specific pathways in mice.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Observational
  12. Article
  13. Too much of a good thing: How modulating LTBSeminars in immunology · 2017
    Review
  14. Article
  15. Pleiotropic regulations of neutrophil receptors response to sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ana Paula T Monteiro1 Instituto de Biofísica Carlos Chagas Filho and.
Erico Soledade
Carla S Pinheiro
Ludmilla Dellatorre-Teixeira
Gisele P Oliveira
Mariana G Oliveira
Marc Peters-Golden
Patricia R M Rocco
Claudia F Benjamim
Claudio Canetti
Universidade Federal do Rio de Janeiro · BRFundação Carlos Chagas · BR

Funding

LEUKOTRIENES AND PULMONARY ANTIBACTERIAL DEFENSER01HL058897 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 1997 to 2012
$4.1M
NHLBI NIH HHS R01 HL058897
6 · The paper itself

Abstract

Postsepsis lung injury is a common clinical problem associated with significant morbidity and mortality. Leukotrienes (LTs) are important lipid mediators of infection and inflammation derived from the 5-lipoxygenase (5-LO) metabolism of arachidonate with the potential to contribute to lung damage after sepsis. To test the hypothesis that LTs are mediators of lung injury after sepsis, we assessed lung structure, inflammatory mediators, and mechanical changes after cecal ligation and puncture surgery in wild-type (WT) and 5-LO knockout (5-LO(-/-)) mice and in WT mice treated with a pharmacologic LT synthesis inhibitor (MK886) and LT receptor antagonists (CP105,696 and montelukast). Sixteen hours after surgery, WT animals exhibited severe lung injury (by histological analysis), substantial mechanical impairment (i.e., an increase in static lung elastance), an increase in neutrophil infiltration, and high levels of LTB4, cysteinyl-LTs (cys-LTs), prostaglandin E2, IL-1β, IL-6, IL-10, IL-17, KC (CXCL1), and monocyte chemotactic protein-1 (CCL2) in lung tissue and plasma. 5-LO(-/-) mice and WT mice treated with a pharmacologic 5-LO inhibitor were significantly protected from lung inflammation and injury. Selective antagonists for BLT1 or cys-LT1, the high-affinity receptors for LTB4 and cys-LTs, respectively, were insufficient to provide protection when used alone. These results point to an important role for 5-LO products in sepsis-induced lung injury and suggest that the use of 5-LO inhibitors may be of therapeutic benefit clinically.

Indexed as

AnimalsArachidonate 5-LipoxygenaseCecumCytokinesInflammationLeukotriene AntagonistsLeukotriene B4Lung InjuryMiceMice, Inbred C57BLNeutrophil InfiltrationReceptors, LeukotrieneReceptors, Leukotriene B4SepsisSignal TransductionArachidonate 5-LipoxygenaseCytokinesLeukotriene AntagonistsLeukotriene B4Ltb4r1 protein, mouseReceptors, LeukotrieneReceptors, Leukotriene B4

Identifiers

PMID23947598
PMCPMC5455351
OpenAlexW2103023415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.